, /PRNewswire/ -- SNP Therapeutics Inc announced today that its Genate Prenatal Nutrition Test can now support healthcare professionals utilizing the Fullscript platform. Participating Fullscript providers will now be able to recommend Genate Prenatal Genetic Nutrition Tests and obtain integrated test recommendations and preliminary Fullscript treatment plans directly within Genate provider test reports. The Genate Test is a prenatal precision nutrition genetic test that identifies metabolic inefficiencies and will inform healthcare providers of their patient's unique gene signature and their unique perinatal nutritional needs.
"We believe that integrating our Genate test with Fullscipt can help to expand the adoption of genetic precision nutrition into reproductive health," said , CEO of SNP Therapeutics. "Integrative Health Practitioners now have an evidence-based precision nutrition tool that can support nutrition recommendations." Common gene variants can impact nutrient metabolism and raise the requirements for certain nutrients, but national recommendations don't take these differences into account.
Until now, prenatal nutrition has been one-size-fits-all, leaving women to guess at whether they need more of specific nutrients. Genate takes out the guesswork by providing women with an evidenced-based plan tailored to their genetics and the nutrition to support their unique needs. Using a machine learning algorithm, the Genate Test evaluates 22 functional genes for 325 va.
